Reply to discrepancies in drug approvals: A global dilemma
Cancer
.
2015 Sep 15;121(18):3361-2.
doi: 10.1002/cncr.29482.
Epub 2015 Jun 16.
Authors
Doreen A Ezeife
1
,
Tony H Truong
2
,
Patricia A Tang
3
Affiliations
1
Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
2
Section of Pediatric Oncology, Department of Oncology, University of Calgary, Calgary, Alberta, Canada.
3
Department of Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
PMID:
26080025
DOI:
10.1002/cncr.29482
No abstract available
Publication types
Letter
Comment
MeSH terms
Antineoplastic Agents*
Drug Approval*
Humans
Substances
Antineoplastic Agents